This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Technische Universitaet Dresden. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Sainitin Donakonda: Innovator in HSP27 Inhibition
Introduction
Sainitin Donakonda is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for heat shock proteins.
Latest Patents
Sainitin Donakonda holds a patent for "Thymine derivatives and quinazoline-dione derivatives for the inhibition of HSP27." This invention relates to novel HSP27 inhibitors, specifically thymine derivatives and phenothiazine derivatives. These compounds are designed for the selective inhibition of the heat shock protein HSP27 (HSPB1), which is particularly relevant in the treatment of carcinomas and cystic fibrosis. The inhibitors demonstrate advantageous activity in the lower micromolar or sub-micromolar active ingredient concentration range.
Career Highlights
Sainitin Donakonda is associated with Technische Universitaet Dresden, where he continues to advance his research in the field. His work focuses on the development of innovative therapeutic agents that target specific proteins involved in disease processes.
Collaborations
He has collaborated with notable colleagues, including Yixin Zhang and Joachim Haupt, to further enhance the impact of his research and inventions.
Conclusion
Sainitin Donakonda's contributions to the field of HSP27 inhibition highlight his innovative spirit and dedication to advancing medical science. His work has the potential to lead to significant advancements in the treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile